SURUNKALI BUYRAK KASALLIGIDA MARKAZIY VA BUYRAK ICHI GEMODINAMIKASINI BAXOLASH BILAN BIRGA ANTIAGREGANT TERAPIYANI MUQOBILLASHTIRISH
Article Sidebar
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Main Article Content
Аннотация:
Surunkali buyrak yetishmovchiligi nefronlar soni va ular funksiyasining progressive tarzda kamayib borishi bilan kechadigan jarayondir. Ma’lumki buyraklarning asosiy vazifasi organism ichki muhiti doimiyligini ya’ni gomeostazni ta’minlashdan iborat. Buyraklar ekskretor va inkretor funksiyasining buzilishi, moddalar almashinuvi hamma turlarining buzilishiga, jumladan kislota-ishqor va elektrolitlar muvozanatining izdan chiqishinatijasida hamma organ va sistemalar faoliyatiga salbiy ta’sir ko’rsatadi. Metobolik o’zgarishlar mikrosirkulyatsiyaning buzilishi, qon reologiyasining yomonlashuviga olib keladi, bu esa o’z navbatida ichki organlar faoliyatini izdan chiqaradi. Surunkali buyrak kasalligi jamiki buyrak ba’zi bir buyrakdan tashqari kasalliklarning asorati hisoblanib u bemorning o’limi bilan yakunlanuvchi patologik jarayondir.
Article Details
Как цитировать:
Библиографические ссылки:
Belousov YU.B, Namsaraev J.N. Endotelialnaya disfunksiya kak prichina ateroskleroticheskogo porajeniya arteriy pri arterialnoy gipertenzii- metodы korreksii. //Farmateka – 2008-№84 – str.. 62–72.
Golovchenko YU.I., Treщinskaya M.A. Obzor sovremennыx predstavleniy ob endotelialnoy disfunksii.// Consilium medicum Ukraina -2008 -№11 - str. 38–40.
Gurevich M.A., Sturov N.V. Defitsit oksida azota i podderjanie sosudistogo gomeostaza- rol mononitratov i problemы sitoproteksii. // Trudnыy patsient - 2011- №3- str. 23–29.
Dzugkoev C.G. Mexanizmы formirovaniya endotelialnoy disfunksii, soprovojdayuщie patologiyu visseralnыx organov pri saxarnom diabete. Puti korreksii // Vestnik novыx meditsinskix texnologiy. - 2013 - №3 – str. 131-138.
Elskiy V. N., Vatutin N. T., Kalinkina N. V., Salaxova A. M. Rol disfunksii endoteliya v geneze serdechno-sosudistыx zabolevaniy. //Jurn. AMN Ukraїni -2013- №14(1)- str. 51–62.
Markov X.M. Rol oksida azota v patogeneze bolezney detskogo vozrasta.// Ros. vestn. perinatol. i pediatr.-2012- №4-str. 43–47.
Movchan E.A. Disfunksiya endoteliya i trombotsitov pri xronicheskoy bolezni pochek: novыy vzglyad na staruyu problemu narusheniy v sisteme gemostaza u bolnыx glomerulonefritom. Byulleten sibirskoy meditsinы, (2008) Prilojenie 2: 88–96.
Stepanov YU.M., Kononov I.N., Jurbina A.I., Filippova A.YU. Arginin v meditsinskoy praktike.// Jurn. AMN Ukraїni -2013-№10(1)- str. 340–352.
Topchiy I.I. Diabeticheskaya nefropatiya – patogeneticheskie labirintы i vozmojnыe terapevticheskie podxodы // «Zdorove Ukrainы» - 2010 - №119 – str. 125-150
Topchiy I.I. Diabeticheskaya nefropatiya - klinika, diagnostika, lechenie i profilaktika xronicheskoy pochechnoy nedostatochnosti // Novosti meditsinы i farmatsii – 2010 – №10(326) – str. 100-103
Anggard E: Nitric oxid: Mediator, murderer, and medicine. Lancet 2014;343:1199-1206.
Adams MR, Jessup W, Celermajer DS: Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: Reversibility with oral L-arginine but not vitamin C. J Am Coll Cardiol 2014;29:491-497.
Appleton J. Arginine: Clinical potential of a semi-essential amino. Altern Med Rev. 2012;7:512-22.
Barnes D. J., Pinto J.R., Viberti G.C. The Patient with Diabetes Mellitus // Oxford Textbook of Clinical Nephrology -2008 - v.2 - P. 723-775
Barbul, A. Arginine: biochemistry, physiology and therapeutic implications. JPEN J Parenter Enteral Nutr 2015. 10:227-238
Barbul A, Sisto DA, Wasserkrug HL, Efron G: Arginine stimulates lymphocyte immune response in healthy human beings. Surgery 2015;90:244-251.
Beasley, D, Brenner, BM. Role of nitric oxide in hemodialysis hypotension. Kidney Int 2009. 42:S96-S100.
Bouby, N, Hassler, C, Parvy, P, Bankir, L. Renal synthesis of arginine in chronic renal failure: In vivo and in vitro studies in rats with 5/6 nephrectomy. Kidney Int 2013. 44:676-683.
Böger R.H. The pharmacodynamics of L-arginine.// J. Nutr. -2013- v.137- P.1650–1655.
Bode-Boger SM, Boger RH, Alfke H, Heinzel D, Tsikas D, Creutzig A, Alexander K, Frolich JC: L-Arginine induces nitric oxide dependent vasodilation in patients with critical limb ischemia. Circulation 2009;93:85-90.
Blumenkrantz, MJ, et al. Protein losses during peritoneal dialysis. Kidney Int 2010.19:593-602.
Bryan N.S., Bian K., Murad F. Discovery of the nitric oxide signaling pathway and targets for drug development.// Frontiers in Bioscience -2009- v.14- P.1–18.
Buhimschi I.A., Saade G.R., Chwalisz K., Garfield R.E. The nitric oxide pathway in pre-eclampsia- pathophysiological implications.// Human Reproduction Update - v.4(1)- P.25–42.
Calver A, Collier J, Moncada S, Vallance P. Effect of local intraarterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens 2009;10: 1025-31
Castillo, L, Bedri, S, Beaumier, L, Ajami, AM, Young, VR. Adaptation to a long term (4 weeks) arginine precursor-free diet in adult humans. FASEB J 2005. 11:439a. (Abstr.)